| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |